Effects of antenatal dexamethasone for maternal antepartum haemorrhage on term babies
Hong Kong Journal of Gynaecology, Obstetrics and Midwifery · 2023
DOI: 10.12809/hkjgom.23.2.341 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hong Kong Journal of Gynaecology, Obstetrics and Midwifery, 2023. Verfasst von Ka-Wai Kong und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Objective
This study aims to compare the outcomes of term babies with or without in utero exposure to dexamethasone as a result of maternal antepartum haemorrhage (APH).
Methods
Medical records of women with antepartum haemorrhage who had a singleton livebirth delivered at ≥37 weeks of gestation in the Queen Elizabeth Hospital, Hong Kong, between 1 January 2019 and 31 December 2021 were retrospectively reviewed.Primary outcomes were the small-for-gestational-age (SGA) rate, the neonatal intensive care unit (NICU) admission rate, and low Apgar score at 5 minutes.Secondary outcomes were the Caesarean section rate and the operative vaginal delivery rate.
Results
A total of 898 women were included; 50 (5.6%) of them had completed a course of antenatal dexamethasone.Compared with women without antenatal dexamethasone, women with antenatal dexamethasone were associated with higher rates of gestational diabetes mellitus (22% vs 7.2%, p
Zitieren
APA
Kong, K., & Leung, K. (2023). Effects of antenatal dexamethasone for maternal antepartum haemorrhage on term babies. Hong Kong Journal of Gynaecology, Obstetrics and Midwifery. https://doi.org/10.12809/hkjgom.23.2.341
Vancouver
Kong K, Leung K. Effects of antenatal dexamethasone for maternal antepartum haemorrhage on term babies. Hong Kong Journal of Gynaecology, Obstetrics and Midwifery. 2023. doi:10.12809/hkjgom.23.2.341
BibTeX
@article{Kong2023,
author = {Kong, Ka-Wai and Leung, Kwok-Yin},
title = {Effects of antenatal dexamethasone for maternal antepartum haemorrhage on term babies},
journal = {Hong Kong Journal of Gynaecology, Obstetrics and Midwifery},
year = {2023},
doi = {10.12809/hkjgom.23.2.341}
}
EUVIMED